PLAY PODCASTS
Calidi Biotherapeutics Inc. (NYSE American: CLDI)  Innovative Platform Targets Tumor Destruction, Long-Term Immune Activation [Video Edition]

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Innovative Platform Targets Tumor Destruction, Long-Term Immune Activation [Video Edition]

The BioMedWire Podcast · [email protected]

July 11, 202514m 38s

Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.